Sarka Kubinova

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

The role of cytokine licensing in shaping the therapeutic potential of wharton's jelly MSCs: metabolic shift towards immunomodulation at the expense of differentiation.

The role of cytokine licensing in shaping the therapeutic potential of wharton's jelly MSCs: metabolic shift towards immunomodulation at the expense of differentiation.

Journal: Stem cell research & therapy

Published: January 14, 2025

Evaluation of Gelatin-Based Poly(Ester Urethane Urea) Electrospun Fibers Using Human Mesenchymal and Neural Stem Cells.

Evaluation of Gelatin-Based Poly(Ester Urethane Urea) Electrospun Fibers Using Human Mesenchymal and Neural Stem Cells.

Journal: Macromolecular bioscience

Published: January 12, 2024

Author Correction: Low oral dose of 4-methylumbelliferone reduces glial scar but is insufficient to induce functional recovery after spinal cord injury.

Author Correction: Low oral dose of 4-methylumbelliferone reduces glial scar but is insufficient to induce functional recovery after spinal cord injury.

Journal: Scientific reports

Published: January 09, 2024

Storage conditions affect the composition of the lyophilized secretome of multipotent mesenchymal stromal cells.

Storage conditions affect the composition of the lyophilized secretome of multipotent mesenchymal stromal cells.

Journal: Scientific reports

Published: November 05, 2023

Low oral dose of 4-methylumbelliferone reduces glial scar but is insufficient to induce functional recovery after spinal cord injury.

Low oral dose of 4-methylumbelliferone reduces glial scar but is insufficient to induce functional recovery after spinal cord injury.

Journal: Scientific reports

Published: July 16, 2023

Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years' multi-stakeholder dialogue on improving access in Europe via MoCA.

Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years' multi-stakeholder dialogue on improving access in Europe via MoCA.

Journal: Orphanet journal of rare diseases

Published: March 16, 2023

4-Methylumbeliferone Treatment at a Dose of 1.2 g/kg/Day Is Safe for Long-Term Usage in Rats.

4-Methylumbeliferone Treatment at a Dose of 1.2 g/kg/Day Is Safe for Long-Term Usage in Rats.

Journal: International journal of molecular sciences

Published: December 23, 2022

Oral treatment of 4-methylumbelliferone reduced perineuronal nets and improved recognition memory in mice.

Oral treatment of 4-methylumbelliferone reduced perineuronal nets and improved recognition memory in mice.

Journal: Brain research bulletin

Published: September 28, 2021

Corrigendum: Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis.

Corrigendum: Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis.

Journal: Frontiers in cell and developmental biology

Published: September 03, 2021

Thiolated poly(2-hydroxyethyl methacrylate) hydrogels as a degradable biocompatible scaffold for tissue engineering.

Thiolated poly(2-hydroxyethyl methacrylate) hydrogels as a degradable biocompatible scaffold for tissue engineering.

Journal: Materials science & engineering. C, Materials for biological applications

Published: May 13, 2021

Retraction Note: Therapeutic effect of molecular hydrogen in corneal UVB-induced oxidative stress and corneal photodamage.

Retraction Note: Therapeutic effect of molecular hydrogen in corneal UVB-induced oxidative stress and corneal photodamage.

Journal: Scientific reports

Published: April 24, 2021

Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis.

Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis.

Journal: Frontiers in cell and developmental biology

Published: April 15, 2021

Showing 1-12 of 69

Last Updated: 09/26/2026